Tobias Bald Selected Research

Purinergic P1 Receptors (Adenosine Receptor)

1/2017

Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Bald Research Topics

Disease

23	Neoplasms (Cancer) 11/2022 - 08/2009
17	Melanoma (Melanoma, Malignant) 11/2022 - 08/2009
8	Inflammation (Inflammations) 01/2021 - 10/2012
2	Neoplasm Metastasis (Metastasis) 12/2017 - 01/2017
2	Contact Dermatitis (Eczema, Contact) 06/2014 - 05/2013
1	Carcinoma (Carcinomatosis) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Viral Bronchiolitis 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	COVID-19 01/2021
1	Cytokine Release Syndrome 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Vascular Tissue Neoplasms 01/2021
1	Chronic Disease (Chronic Diseases) 10/2020
1	Visceral Leishmaniasis (Kala Azar) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Multiple Myeloma 01/2018
1	Disease Progression 01/2018
1	Pathologic Neovascularization 11/2016
1	Amelanotic Melanoma (Amelanotic Melanomas) 01/2016
1	Neurofibrosarcoma (MPNST) 01/2016
1	Skin Neoplasms (Skin Cancer) 10/2015
1	Papilloma (Papillomatosis) 10/2015
1	Fibrosarcoma 10/2015
1	Atopic Dermatitis (Atopic Eczema) 06/2014
1	Dermatitis 06/2014
1	Autoimmune Diseases (Autoimmune Disease) 09/2013
1	Infections 09/2013
1	Bites and Stings (Sting) 09/2013
1	Allergic Contact Dermatitis 05/2013
1	Necrosis 10/2012

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 11/2022 - 01/2017
5	AntigensIBA 01/2021 - 08/2009
5	CytokinesIBA 01/2020 - 10/2012
4	LigandsIBA 11/2022 - 10/2017
4	Proteins (Proteins, Gene)FDA Link 10/2020 - 08/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	ChemokinesIBA 01/2020 - 07/2011
3	CannabinoidsIBA 10/2015 - 05/2013
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	InterleukinsIBA 01/2021 - 01/2018
2	PlasticsIBA 01/2021 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2017
2	Interleukin-18 (Interleukin 18)IBA 01/2020 - 01/2018
2	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 01/2017
2	EnzymesIBA 01/2017 - 01/2017
2	CarcinogensIBA 02/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 09/2013
1	Biological ProductsIBA 11/2022
1	Interferon LambdaIBA 01/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2022
1	Small Cytoplasmic RNAIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2021
1	Poly I-CIBA 01/2021
1	apabetaloneIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 10/2020
1	src-Family KinasesIBA 10/2020
1	Interferon Type IIBA 01/2020
1	EpitopesIBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	InflammasomesIBA 12/2019
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2017
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017
1	dabrafenibIBA 01/2017
1	trametinibIBA 01/2017
1	Netrin-1IBA 11/2016
1	Netrin ReceptorsIBA 11/2016
1	Phorbol EstersIBA 02/2016
1	9,10-Dimethyl-1,2-benzanthraceneIBA 01/2016
1	Chemotactic FactorsIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 11/2015
1	Dronabinol (THC)FDA LinkGeneric 10/2015
1	CB2 Cannabinoid ReceptorIBA 10/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 06/2014
1	isothiocyanic acidIBA 06/2014
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 06/2014
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2014
1	Antiviral Agents (Antivirals)IBA 09/2013
1	Nucleic AcidsIBA 08/2009

Therapy/Procedure

15	Immunotherapy 11/2022 - 10/2012
10	Therapeutics 01/2021 - 10/2012
2	Transplantation 01/2015 - 10/2012
2	Injections 06/2014 - 08/2009
1	ACT protocol 10/2012